Posts by: Iqra Mumal

News

Biohaven Pharmaceuticals has established an expanded access program (EAP) for patients with amyotrophic lateral sclerosis (ALS) for its investigational treatment candidate, BHV-0223, the company recently announced. The United States Food ... Read more

May 1, 2018

New System Mimics Human Testing of Therapies for Neuromuscular Junction Diseases Like ALS

News

New technology that tests therapies designed for disorders of the neuromuscular junction, such as amyotrophic lateral sclerosis (ALS), closely mimics the human condition and offers a new method of ... Read more

April 9, 2018April 9, 2018

Lack of Enzyme Crimps Movement Nerve Cell Development, Study Suggests

News

Lack of an enzyme prevents movement nerve cells from developing properly, suggesting that the shortage may play a role in ALS, a Northwestern University study reports. The study in the ... Read more

March 16, 2018March 16, 2018

RNA-Protein Interaction Is Essential to Nerve Cell Communication, Study Finds

News

The interaction between an RNA molecule and a protein is essential for the growth of axons, the portion of movement nerve cells responsible for communicating with other nerve cells, a study ... Read more

March 14, 2018March 14, 2018

ALS-Linked Protein FUS Plays Major Role in Gene Expression, Study Finds

News

Scientists have discovered a key role for the ALS-linked protein known as fused in sarcoma (FUS) in a system that is crucial to regulating gene expression. The study, “FUS ... Read more

March 13, 2018March 13, 2018

Researchers Obtain Further Insight into Protein Whose Mutations Are Linked to ALS

News

Syracuse University researchers have obtained further insight into the protein UBQLN2, whose mutations have been associated with the development of amyotrophic lateral sclerosis (ALS). The study, “Ubiquitin Modulates Liquid-Liquid ... Read more

March 2, 2018March 2, 2018

Study Sheds More Light on Nucleolus, an Organelle Linked to ALS

News

Scientists have gained greater insight into the structure of the nucleolus, a cellular organelle that has been implicated in diseases such as amyotrophic lateral sclerosis (ALS). By honing in ... Read more

February 9, 2018February 9, 2018

Need for Assistive Technology Devices Often Unmet, German Study Shows

News

Researchers in Germany studying standards of care in amyotrophic lateral sclerosis (ALS) patients found a high unmet need for assistive technology devices. The cohort study, “Provision of assistive technology devices ... Read more

January 3, 2018

High School Diploma Lowers Risk of Dementia and Cognitive Impairment in Rural Areas, Study Finds

News

Rural residents with high school diplomas are at lower risk of developing dementia and cognitive impairment than those with less education, a study indicates. The study has healthcare policy ... Read more

December 18, 2017

MediciNova’s MN-166 Is Safe, Shows Early Signs of Efficacy in Phase 2 Trial

News

MediciNova announced successful top-line results from a Phase 2 clinical trial of MN-166 (ibudilast) as an adjunct therapy to Rilutek (riluzole) in patients with amyotrophic lateral sclerosis (ALS). The treatment ... Read more

Posts by: Iqra Mumal

Iqra Mumal

Biohaven Establishes Expanded Access Program for Investigational ALS Therapy BHV-0223

New System Mimics Human Testing of Therapies for Neuromuscular Junction Diseases Like ALS

Lack of Enzyme Crimps Movement Nerve Cell Development, Study Suggests

RNA-Protein Interaction Is Essential to Nerve Cell Communication, Study Finds

ALS-Linked Protein FUS Plays Major Role in Gene Expression, Study Finds

Researchers Obtain Further Insight into Protein Whose Mutations Are Linked to ALS

Study Sheds More Light on Nucleolus, an Organelle Linked to ALS

Need for Assistive Technology Devices Often Unmet, German Study Shows

High School Diploma Lowers Risk of Dementia and Cognitive Impairment in Rural Areas, Study Finds

MediciNova’s MN-166 Is Safe, Shows Early Signs of Efficacy in Phase 2 Trial

Pin It on Pinterest